Even Medical Marijuana Research is Set to Benefit from Banking Reform

Lawmakers are once again trying to give the green light to cannabis banking legislation in states where it’s legal. With classic banking services potentially becoming available for marijuana dispensaries, how will this impact the sale of medical-grade cannabis products? Michael Sassano, the Chairman and CEO at Somai Pharmaceuticals weighs in.

With these potential developments, it begs the question: does this banking reform open the door for a more frictionless research pipeline? Michael shares some interesting statistics on where things stand researching cannibanoids for pharmaceuticals and medical applications.


Follow us on social media for the latest updates in B2B!


Breaking Glass with Nancy Novak: Confronting Implicit Bias in the Workplace
October 18, 2021
“Implicit bias isn’t always visible. It’s not always as concrete as bringing in people with differences.” Implicit bias is subconscious and not recognized by those impacted by it. So, how can companies Read more
Impressions: Hot Trends in Self-Storage for 2021
October 18, 2021
  RV and boat purchases are up, creating new opportunities for self-storage tenants and self-storage operators offering enhanced protection on renters’ valuable assets. Jacquelyn Nash, Sr. Account Executive Read more
Math Proficiency Scores Decline Nationwide
As Math Proficiency Scores Decline Nationwide, How Should Curriculum Shift?
October 18, 2021
  Disruptions to education during the pandemic had a serious impact on knowledge retention and student performance, and it's bearing out in assessment numbers. Whether it's a fault in the Read more